Literature DB >> 3422290

A comparison of the reactivity of Eubacterium species with localized and serum immunoglobulins from rapidly progressive and adult periodontitis patients.

S A Martin1, W A Falkler, J W Vincent, B F Mackler, J B Suzuki.   

Abstract

Immunoglobulins in sera and in supernatant fluids of explant cultures of diseased gingival tissues from 20 rapidly progressive and 20 adult periodontitis sites were tested by an ELISA assay for reactivity with typed strains of Eubacterium alactolyticum, E. brachy, E. limosum and E. nodatum. Immunoglobulins present in tissue culture fluids from both rapidly progressive and adult periodontitis samples reactive with E. brachy and E. nodatum were significantly greater (P less than 0.05) than those reactive with E. alactolyticum or E. limosum. The titers to E. brachy in tissue culture fluids from adult periodontitis were significantly greater (P less than 0.05) than those from rapidly progressive periodontitis; there was no difference in titers to the other three species. The only significant difference in serum titers was that sera from patients with rapidly progressive periodontitis had significantly greater reactivity to E. alactolyticum than did sera from adult periodontitis patients. These data indicate that immunoglobulins in the sera of rapidly progressive and adult periodontitis patients do not necessarily reflect the reactivity of localized immunoglobulins present in the diseased gingival tissue explant culture fluids from these patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3422290     DOI: 10.1902/jop.1988.59.1.32

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  1 in total

1.  A case of relapsed lung abscess caused by Eubacterium brachy infection following an initial diagnosis of pulmonary actinomycosis.

Authors:  Hideaki Yamakawa; Eri Hagiwara; Masahiro Hayashi; Takuma Katano; Kosuke Isomoto; Ryota Otoshi; Ryota Shintani; Satoshi Ikeda; Kaori Tanaka; Takashi Ogura
Journal:  Respir Med Case Rep       Date:  2017-08-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.